An Act to amend the Public Health Service Act to enlarge the authority of the National Health and Lung Institute in order to advance the national attack against diseases of the heart and blood vessels, the lungs, and blood, and for other purposes
PL 92-423 (S.3323), enacted 09/19/1972

86 STAT. ] 
PUBLIC LAW 92-423-SEPT. 19, 1972 
679 
(b) The design and plans for such memorial shall be subject to 
the approval of the Secretary of the Interior, the National Comrnis-
sion of Fine Arts, and the National Capital Planning Commission, 
and the United States or the District of Columbia shall be put to no 
expense in the erection thereof. 
SEC. 3. The authority conferred pursuant to this joint resolution 
shall lapse unless (1) the erection of such memorial is commenced 
within five years from the date of enactment of this joint resolution, 
and (2) prior to its commencement funds are certified available in an 
amount sufficient, in the judgment of the Secretary of the Interior, to 
insure completion of the memorial. 
SEC. 4. The maintenance and care of the memorial erected under 
the provisions of this Act shall be the responsibility of the Secretary 
of the Interior, or, if the memorial is erected upon public grounds 
belonging to or under the jurisdiction of the Distiict of Columbia, 
the government of the District of Columbia. 
Approved September 18, 1972. 
Approval. 
Conditions. 
Maintenance 
and care. 
Public Law 92-423 
AN ACT 
To amend the Public Health Service Act to enlarge the aiitliority of the National 
Heart and Lung Institute in order to advance the national attack against 
diseases of the heart and blood vessels, the lungs, and blood, and for other 
puri)oses. 
September 19,1972 
[S. 3323] 
Be it enacted by the l:^enate and Houm of Reprenenfat/rey 
of the 
United, Staten of Am erica in CongresH an^ewhl 
ed 
^ 
SHORT T r r L E 
SECTION 1. This Act may be cited as the ""National Heart. Hlood 
Vessel, Lung, and Blood Act of 1972". 
P T N D I N G S 
A N D DECLARA'ITON OF PTRI'OSK 
SEC. 2. (a) Congress finds and declares that^— 
(1) diseases of the heart and blood vessels collectively cause 
more than half of all the deaths each year in the Ignited States 
and the combined effect of the disabilities and deaths from such 
diseases is having a major social and economic impact on the 
Nation; 
(2) elimination of heart and blood vessel diseases as significant 
causes of disability and death could increase the average Ameri-
can's life expectancy by about eleven years and could provide for 
annual savings to the economy in lost wages, productivity, and 
costs of medical care of more than $30,000,000,000 per year; 
(3) chronic lung diseases have been gaining steadily in recent 
years as important causes of disability and death, with emphysema 
alone being the fastest rising cause of death in the United States; 
(4) chronic respiratory diseases affect an estimated ten million 
Americans, emphysema an estimated one million, chronic bron-
chitis an estimated four million, and asthma an estimated five 
million; 
(5) thrombosis (the formation of blood clots in the vessels) 
may cause, directly or in combination with other problems, many 
deaths and disabilities from heart disease and stroke which can 
now be prevented; 
National Heart, 
Blood Vessel, 
Lung, and Blood 
Act of 1972. 
82-081 O - 73 - 46 
680 
PUBLIC LAW 92-423-SEPT. 19, 1972 
[86 STAT. 
(6) blood and blood products are essential human resources 
whose value in saving life and promoting liealth cannot be 
assessed in terms of dollars; 
(7) the provision of prompt and effective emergency medical 
services utilizing to the fullest extent possible advances in trans-
portation and communications and other electronic systems and 
specially trained professional and paraprofessional health care 
personnel can reduce substantially the number of fatalities and 
severe disabilities due to critical illnesses in connection with heart, 
blood vessel, lung, and blood diseases; and 
(8) the greatest potential for advancement against heart, blood 
vessel, lung, and blood diseases lies in the National Heart and 
Lung Institute, but advancement against such diseases depends 
not only on the research programs of that Institute but also on 
the research programs of other research institutes of the National 
Institutes of Health. 
(b) It is the purpose of this Act to enlarge the authority of tlie 
National Heart and Lung Institute in order to advance the national 
nttack upon heart, blood vessel, lung, and blood diseases. 
JIEAKT, BLOOD VE8SKI., 1A^N(}, AND BLOOD DISEASE PR0<iRAMS 
62 Stat. 464. 
SEC. 8. Part B of title IV of the Public Health Service Act is 
42 use 287. 
amended (1) by redesignating section 418 as section 419A. (2) by 
redesignating section 414 as section 418, and (3) by adding after sec-
tion 412 the following new sections: 
" N A T I O N A L H E A R T , BLOOD VESSEL, LUN(}, AND BLOOD DISEASE PROGRAM 
"SEC. 413. (a) The Director of the Institute, with the advice of the 
Council, shall develop a plan for a National Heart, Blood Vessel, 
Lung, and Blood Disease Program (hereafter in this part referred 
to as the 'Program') to expand, intensify,"and coordinate the activities 
of the Institute respecting heart, blood vessel, lung, and blood diseases 
(including its activities under section 412) and shall carry out the 
NiH, coordina- 
Program in accordance with such plan. The Program shall be coordi-
tion provisions. 
nated with the other research institutes of the National Institutes of 
Health to the extent that they have responsibilities respecting such 
diseases and shall provide for— 
"(1) investigation into the epidemiology, etiology, and preven-
tion of all forms and aspects of heart, blood vessel, lung, and blood 
diseases, including investigations into the social, environmental, 
behavioral, nutritional, biological, and genetic determinants and 
influences involved in the epidemiology, etiology, and prevention 
of such diseases; 
" (2) studies and research into the basic biological processes and 
mechanisms involved in the underlying normal and abnormal 
heart, blood vessel, lung, and blood phenomena; 
"(3) research into the development, trial, and evaluation of 
techniques, drugs, and devices (including computers) used in, 
and approaches to, the diagnosis, treatment (including emergency 
medical service), and prevention of heart, blood vessel, lung, and 
blood diseases and the rehabilitation of patients suffering from 
such diseases; 
,., 
86 STAT. ] 
PUBLIC LAW 92-423-SEPT. 19, 1972 
681 
"(4) establishment of programs that will focus and apply sci-
entific and technological efforts involving biological, physical, and 
engineering sciences to all facets of heart, blood vessel, lung, and 
blood diseases with emphasis on refinement, development, and 
evaluation of technological devices that will assist, replace, or 
monitor vital organs and improve instrumentation for detection, 
diagnosis, and treatment of those diseases; 
"(5) establishment of programs for the conduct and direction 
of field studies, large-scale testing and evaluation, and demon-
stration of preventive, diagnostic, therapeutic, and rehabilitative 
approaches to, and emergency medical services for, such diseases; 
(6) studies and research into blood diseases and blood, and 
into the use of blood for clinical purposes and all aspects of the 
management of its resources in this country, including the collec-
tion, preservation, f 
ractionalization, and distribution of it and its 
products; 
"(7) the education and training of scientists, clinicians, and 
educators, in fields and specialties (including computer sciences) 
requisite to the conduct of programs respecting heart, blood ves-
sel, lung, and blood diseases; 
"(8) public and professional education relating to all aspects 
of such diseases and the use of blood and blood products and the 
• • 
management of blood resources: 
"(9) establishment of programs for study and reseai'ch into 
heart, blood vessel, lung, and blood diseases of children (includinor 
cystic fibrosis, hyaline membrane, and hemolytic and hemophilic 
diseases) and for the development and demonstration of diagnos-
tic, treatment, and preventive approaches to these diseases; and 
"(10) establishment of programs for study, research, develop-
ment, demonstrations and evaluation of emergency medical serv-
ices for people who become critically ill in connection with heart, 
blood vessel, lung, or blood diseases, which programs shall 
include programs for (A) the training of paraprofessionals in 
(i) emergency treatment procedures, and (ii) utilization and oper-
ation of emergency medical equipment, (B) the development and 
operation of (i) mobile critical care units (including helicopters 
and other airborne units where appropriate), (ii) radio, tele-
communications, and other means of communications, and (iii) 
electronic monitoring systems, and (C) the coordination with 
other community services and agencies in the joint use of all forms 
of emergency vehicles, communications systems, and other appro-
priate services. 
The Program shall give special emphasis to the continued develop- 
^^*'f°Ne^ lou^'. 
ment in the Institute of programs relating to atherosclerosis, hyper- ical Disea"sTs"fnd 
tension, thrombosis, and congenital abnormalities of the blood vessels stroke, coordina-
as causes of stroke, and to effective coordination of such programs ''°"' 
with related stroke programs in the National Institute of Neurological 
Diseases and Stroke. 
"(b) (1) The plan required by subsection (a) of this section shall 
(A) be developed within one hundred and eighty days after the effec-
tive date of this section, (B) be transmitted to the Congress, and (C) 
set out the Institute's staff requirements to carry out the Program and 
lecommendations for appropriations for the Program. 
Plan develop-
ment; transmittal 
to Congress. 
682 
PUBLIC LAW 92-423-SEPT. 19, 1972 
[86 
STAT. 
Report to Presi-
dent, transmittal 
to Congress. 
Director, func-
tions. 
80 Stat. 416. 
19 Stat. 370. 
Assistant Direc-
tor for Health In-
formation Pro-
grams. 
Cardiovascular 
and pulmonary 
diseases, infor-
mation. 
" (2) The Director of the Institute shall, as soon as practicable after 
the end of each calendar year, prepare in consultation with the Coun-
cil and submit to the President for transmittal to the Congress a 
report on the activities, progress, and accomplishments under the 
Program during the preceding calendar year and a plan for the Pro-
gram during the next five years. 
"(c) In carrying out the Program, the Director of the Institute, 
under policies established by the Director of the National Institutes 
of Health and after consultation with the Council and without regard 
to any other provision of this Act, may— 
"(1) if authorized by the Council, obtain (in accordance with 
section 3109 of title 5, United States Code, but without regard to 
the limitation in such section on the number of days or the period 
of such service) the services of not more than fifty experts or con-
sultants who have scientific or professional qualifications; 
"(2) acquire, construct, improve, repair, operate, and maintain 
heart, blood vessel, lung, and blood disease laboratory, research, 
training, and other necessary facilities and equipment, and related 
accommodations as may be necessary, and such other real or per-
sonal property (including patents) as the Director deems neces-
sary; and acquire, without regard to the Act of March 3, 1877 
(40 U.S.C. 34), by lease or otherwise, through the Administrator 
of General Services, buildings or parts, of buildings in the District 
of Columbia or communities located adjacent to the District of 
Columbia for the use of the Institute for a period not to exceed 
ten years; and 
"(3) enter into such contracts, leases, cooperative agreements, 
or other transactions, without regard to sections 3648 and 3709 of 
the Eevised Statutes of the United States (31 U.S.C. 529,41 U.S.C. 
5), as may be necessary in the conduct of his functions, with any 
public agency, or with any person, firm, association, corporation, 
or educational institution. 
"(d) There shall be in the Institute an Assistant Director for Health 
Information Programs who shall be appointed by the Director of the 
Institute. The Director of the Institute, acting through the Assistant 
Director for Health Information Programs, shall conduct a program 
to provide the public and the health professions with health informa-
tion with regard to cardiovascular and pulmonary diseases. In the 
conduct of such program, special emphasis shall be placed upon dis-
semination of information regarding diet, exercise, stress, hyperten-
sion, cigarette smoking, weight control, and other factors affecting the 
prevention of arteriosclerosis and other cardiovascular diseases and of 
pulmonary diseases. 
"HEART, BLOOD VESSEL, LUNG, AND BLOOD DISEASE PREVENTION AND 
CONTROL PROGRAMS 
"SEC. 414. (a) The Director of the Institute, under policies estab-
lished by the Director of the National Institutes of Health and after 
consultation with the Council, shall establish programs as necessary 
for cooperation with other Federal Health agencies, State, local, and 
regional public health agencies, and nonprofit private health agencies 
in the diagnosis, prevention, and treatment (including the provision 
of emergency medical services) of heart, blood vessel, lung, and blood 
86 STAT. ] 
PUBLIC LAW 92-423-SEPT. 19, 1972 
683 
diseases, appropriately emphasizing the prevention, diagnosis, and 
treatment of such diseases of children. 
"(b) There is authorized to be appropriated to carry out this 
Appropriations. 
section $25,000,000 for the fiscal year ending June 30,1973, $35,000,000 
for the fiscal year ending June 30, 1974, and $45,000,000 for the fiscal 
year ending June 30,1975. 
"NATIONAL RESEARCH AND DEMONSTRATION CENTERS FOR HEART, BLOOD 
VESSEL, LUNG, AND BLOOD DISEASES 
"SEC. 415. (a) (1) The Director of the Institute may provide for the 
development of— 
"(A) fifteen new centers for basic and clinical research into, 
training in, and demonstration of, advanced diagnostic, preven-
tion, and treatment methods (including methods of providing 
emergency medical services) for heart, blood vessel, and blood 
diseases; and 
"(B) fifteen new centers for basic and clinical research into, 
training in, and demonstration of, advanced diagnostic, preven-
tion, and treatment methods (including methods of providing 
emergency medical services) for chronic lung diseases (including 
bronchitis, emphysema, asthma, cystic fibrosis, and other lung 
diseases of children). 
"(2) The centers developed under paragraph (1) (A) shall, in 
addition to being utilized for research, training, and demonstrations, 
be utilized for the following prevention programs for cardiovascular 
diseases: 
"(A) Programs to develop improved methods of detecting 
individuals with a high risk of developing cardiovascular disease. 
"(B) Programs to develop improved methods of intervention 
against those factors which cause individuals to have a high risk 
of developing such disease. 
"(C) Programs to develop health professions and allied health 
professions personnel highly skilled in the prevention of such 
disease. 
"(D) Programs to develop improved methods of providing 
emergency medical services for persons with such disease. 
"(3) Centers developed under this subsection may be supported 
under subsection (b) or under any other applicable provision of law. 
The research, training, and demonstration activities carried out 
through any such center may relate to any one or more of the diseases 
referred to in paragraph (1) of this subsection. 
"(b) The Director of the Institute, under policies established by the 
Public or non-
Director of the National Institutes of Health and after consultation cooplrau^ve'ag^e-
with the Council, may enter into cooperative agreements with public or ments. 
nonprofit private agencies or institutions to pay all or part of the cost 
of planning, establishing, or strengthening, and providing basic oper-
ating support for, existing or new centers (including centers estab-
lished under subsection (a)) for basic or clinical research into, training 
in, and demonstration of, advanced diagnostic, prevention, and treat-
ment methods for heart, blood vessel, lung, or blood diseases. Funds 
^^^ °^ ^""'^^• 
paid to centers under cooperative agreements under this subsection 
may be used for— 
"(1) construction, notwithstanding section 405, 
ss stat. yos. 
"(2) staffing and other basic operating costs, including such 
"
^
^ use 285. 
patient care costs as are required for research. 
684 
PUBLIC LAW 92-423-SEPT. 19, 1972 
[86 STAT. 
Limitations. 
"Construction. 
Establishment. 
Establishment; 
membership. 
Terms. 
"(3) training, including training for allied health professions 
personnel, and 
"(4) demonstration purposes. 
The aggregate of payments (other than payments for construction) 
made to any center under such an agreement may not exceed $5,000,000 
in any year. Support of a center under this subsection may be for a 
period of not to exceed five years and may be extended by the Director 
of the Institute for additional periods of not more than five years each, 
after review of the operations of such center by an appropriate scien-
tific review group established by the Director. As used in this section, 
the term 'construction' does not include the acquisition of land. 
u 
INTERAGENCY TECHNICAL COMMITTEE 
"SEC. 416. (a) The Secretary shall establish an Interagency Tech-
nical Committee on Heart, Blood Vessel, Lung and Blood Diseases 
and Blood Eesources which shall be responsible for coordinating those 
aspects of all Federal health programs and activities relating to heart, 
blood vessel, lung, and blood diseases and to blood resources to assure 
the adequacy and technical soundness of such programs and activities 
and to provide for the full communication and exchange of informa-
tion necessary to maintain adequate coordination of such programs and 
activities. 
"(b) The Director of the Institute shall serve as Chairman of the 
Committee and the Committee shall include representation from all 
Federal departments arid agencies whose programs involve health 
functions or responsibilities as determined by the Secretary. 
" N A T I O N A L H E A R T AND LUNG ADVISORY COUNCIL 
"SEC. 417. (a) There is established in the Institute a National Heart 
and Lung Advisory Council to be composed of twenty-three members 
as follows: 
"(1) The Secretary, the Director of the National Institutes of 
Health, the Director of the Office of Science and Technology, and 
the chief medical officer of the Veterans' Administration (or their 
designees), and a medical officer designated by the Secretary of 
Defense, shall be ex officio members of the Council. 
" (2) Eighteen members appointed by the Secretary. 
Eleven of the appointed members shall be selected from among the 
leading medical or scientific authorities who are skilled in the sciences 
relating to diseases of the heart, blood vessels, lungs, and blood; two 
of the appointed members shall be selected from persons enrolled in 
residency programs providing training in heart, blood vessel, lung, or 
blood diseases; and five of tne appointed members shall be selected 
from members of the general public who are leaders in the fields of 
fundamental or medical sciences or in public affairs. 
"(b) (1) Each appointed member of the Council shall be appointed 
for a term of four years, except that— 
"(A) any member appointed to fill a vacancy occurring prior 
to the expiration of the term for which his predecessor was 
86 STAT. ] 
PUBLIC LAW 92-423-SEPT. 19, 1972 
685 
appointed shall be appointed for the remainder of such term; and 
"(B) of the members first appointed after the effective date of 
this section, five shall be appointed for a term of four years, five 
shall be appointed for a term of three years, 
five 
shall be appointed 
for a term of two years, and three shall be appointed for a term 
of one year, as designated by the Secretary at the time of 
appointment. 
Appointed members may serve after the expiration of their terms until 
their successors have taken office. 
"(2) A vacancy in the Council shall not affect its activities, and 
twelve members of the Council shall constitute a quorum. 
"(3) The Council shall supersede the existing National Advisory 
Heart Council appointed under section 217, and the appointed mem-
bers of the National Advisory Heart Council serving on the effective 
date of this section shall serve as additional members of the National 
Heart and Lung Advisory Council for the duration of their terms 
then existing, or for such shorter time as the Secretary may prescribe. 
"(4) Members of the Council who are not officers or employees of 
the United States shall receive for each day they are engaged in the 
performance of the functions of the Council compensation at rates 
not to exceed the daily equivalent of the annual rate in effect for grade 
GS-18 of the General Schedule, including traveltime; and all mem-
bers, while so serving away from their homes or regular places of 
business, may be allowed travel expenses, including per diem in lieu 
of subsistence, in the same manner as such expenses are authorized by 
section 5703 of title 5, United States Code, for persons in the Govern-
ment service employed intermittently. 
"(c) The Secretary (or his designee) shall be the Chairman of the 
Council. 
"(d) The Director of the Institute shall (1) designate a member of 
the staff of the Institute to act as Executive Secretary of the Council, 
and (2) make available to the Council such staff, information, and 
other assistance as it may require to carry out its functions. 
" (e) The Council shall meet at the call of the Chairman, but not less 
often than four times a year." 
Extension. 
National Advi-
sory Heart Coun-
cil, replacement 
provisions. 
64 Stat. 446. 
42 u s e 218. 
5 u s e 5332 
note. 
80 Stat. 499; 
83 Stat. 190. 
Executive Sec-
retary. 
AUTHORIZATION OP APPROPRIATIONS FOR PART B OF TITLE IV OF TIIE PUBLIC 
HEALTH SERVICE ACT 
SEC. 4. Part B of title IV of the Public Health Service Act is 
amended by adding at the end thereof the following new section: 
Ante, 
p. 680. 
" A U T H O R I Z A T I O N 
O F 
APPROPRIATIONS 
"SEC. 419B. For the purpose of carrying out this part (other than 
section 414), there is authorized to be appropriated $375,000,000 for 
the fiscal year ending June 30, 1973, $425,000,000 for the fiscal year 
ending June 30, 1974, and $475,000,000 for the fiscal year ending 
June 30, 1975. Of the sums appropriated under this section for any 
fiscal year, not less than 15 per centum of such sums shall be reserved 
Ante, 
p. 682. 
686 
PUBLIC LAW 92-423-SEPT. 19, 1972 
[86 STAT. 
for pro<j:ranis under this part respecting- diseases of the lung and not 
less than 15 per centum of sucli sums shall be reserved for programs 
under this pait for projirams respectiuj^ diseases of the blood." 
Limitations. 
AITHOKITY o r THE DIRECTOR OF THE NATIONAE HEART AXI) LI NO 
INSTITI'TE TO APPROVE GRANTS 
SEC. .5. Section -H9A of the Public Healtli Service Act (as so 
redesignated by section 8 of this Act) is amended— 
(1) by striking out "grants-in-aid" in subsection (a) and 
inserting in lieu thereof "except as i)rovided in subsection (c), 
grants-in-aid"; and 
(2) by adding after 
subsection 
(b) 
the following 
new 
subsection: 
"(e) lender procedures approved by the Director of the ^'ationa] 
Institutes of Health, the Director of the National Heart and Lung 
Institute may approve grants under this Act for research and training 
in heart, blood vessel, lung, and blood diseases— 
"(1) in amounts not to exceed $35,000 after appropriate review 
for scientific merit but without review and recommendation by 
the Council, and 
"(2) in amounts exceeding $;^5,000 after appropriate review 
for scientific merit and reconmiendation for approval by the 
Council." 
62 Stat. 465. 
42 u s e 287. 
42 use 287a. 
Ante, p. 680. 
Report to Pres-
ident, transmittal 
to Congress. 
CONE0RMlX(i AMENDMENTS TO PART B OF TITLE IV OF THE PI BLU" HEALTH 
SERVICE ACT 
SEC. 6. (a) Section 4:11 of the Public Health Service Act is amended 
l)y striking out "National Heart Institute" and inserting in lieu 
thereof "National Heart and Lung Institute". 
(b) Section 412 of such Act is amended— 
(1) by striking out "heart" each place it occurs (except in the 
heading) and inseiting in lieu thereof "heart. V)lood vessel, lung, 
and blood"; 
(2) by striking out "Surgeon (xeneral" and inserting in lieu 
thereof "Secretary"; 
(8) by striking out "National Advisory Heart Council" and 
inserting in lieu thereof "National Heart and Lung Advisoi-y 
Council"; 
(4) by redesignating paragraphs (a), (b), (c), (d). (e), (f), 
and (g) as paragraphs (1). (2), (8). (4). (5), (6). and (T), 
respectively; and 
(5) by amending the section heading to i-ead as follows: 
" R E S E A R C H A N D T R A I N I N G I N DISEASES OF THE HEART. BLOOD VESSELS, 
LUNG. AND 
BLOOD" 
(c) Section 418 of such Act (as so redesignated by section 8 of this 
Act) is amended— 
(1) by inserting " ( a ) " immediately after "SEC. 418." and by 
adding at the end thereof the following new subsection : 
"(b)(1) The Council shall advise and assist the Directoi; of the 
Institute with respect to the Program established under section 418. 
The Council may hold such hearings, take such testimony, and sit and 
act at such times and places, as the Council deems advisable to inves-
tigate programs and activities of the Program. 
"(2) The Council shall submit a report to the President for trans-
mittal to the Congress not later than January 31 of each year on the 
progress of the Program toward the accomplishment of its objectives." 
86 STAT. ] 
PUBLIC LAW 92-423-SEPT. 19, 1972 
687 
(2) by striking out "Surgeon General" each place it occurs 
(except paragraph (f)) and inserting in lieu thereof "Secretary"; 
(3) by striking out "heart" each place it occurs and inserting 
in lieu thereof "heart, blood vessel, lung, and blood"; 
(4) by striking out "Surgeon General" in paragraph (f) and 
inserting in lieu thereof "Secretary, the Director of the National 
Institutes of Health, and the Director of the National Heart and 
Lung Institute"; and 
(5) by redesignating paragraphs (a), (b), (c), (d), (e), and 
(f) as paragraplis (1), (2), (3), (4), (5), and (6), respectively. 
(d) Section 419A of such Act (as so redesignated by section 3 of 
this Act) is amended— 
(1) in subsection (a), by (A) striking out "Surgeon General" 
and inserting in lieu thereof "Secretary", and (B) striking out 
"heart" and inserting in lieu thereof "heart, blood vessel, lung, 
and blood"; and 
(2) in subsection (b), by (A) striking out "The Surgeon Gen-
eral shall recommend to the Secretary acceptance of conditional 
§ifts, pursuant to section 501," and inserting in lieu thereof "The 
^^ ^*^^- ^
^
"
g
^
-
ecretary may, in accordance with section 501, accept conditional 
gifts", and (B) striking out "heart" and inserting in lieu thereof 
"heart, blood vessel, lung, and blood". 
(e) The heading for part B of such Act is amended to read as 
follows: 
"PART B—NATIONAL HEART AND LUNG INSTITUTE". 
CONFORMING AMENDMENTS TO OTHER PROVISIONS OF THE PUBLICO 
HEALTH SERVICE ACT 
SEC. 7. (a) Section 217 of such Act is amended— 
52 us^c 2it. 
(1) by striking out "the National Advisory Heart (^ouncil," 
each place it occurs in subsection (a); 
(2) by striking out "heart diseases," in subsection (a) and by 
striking out "heart," in subsection (b). 
(b) Sections 301(d) and 301 (i) of such Act are each amended by 
JI^H^'^Q^^.^' 
striking out "National Advisory Heart Council" and inserting in lieu 79 stat! 443! 
thereof "National Heart and Lung Advisory Council". 
42 use 241. 
REPORT TO CONGRESS 
SEC. 8. The Secretary of Health, Education, and Welfare shall carry 
Review. 
out a review of all administrative processes under which the National 
Heart, Blood Vessel, Lung, and Blood Disease Program, established 
under part B of title IV of the Public Health Service Act, will operate, 
^nte, p. eso. 
including the processes of advisory council and peer group reviews, in 
order to assure the most expeditious accomplishment of the objectives 
of the Program. Within one year of the date of enactment of this Act, 
the Secretary shall submit a report to the Congress of the findings of 
such review and the actions taken to facilitate the conduct of the Pro-
gram, together with recommendations for any needed legislative 
changes. 
EFFECTIVE DATE 
SEC. 9. This Act and the amendments made by this Act shall take 
eJBfect sixty days after the date of enactment of this Act or on such 
Publication in 
prior date after the date of enactment of this Act as the President ^^'^^'^^ Register. 
shall prescribe and publish in the Federal Eegister. 
Approved September 19, 1972.